Beta-galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells
- PMID: 2121639
- DOI: 10.1007/BF00194225
Beta-galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells
Abstract
COS-1 cells were transfected by electroporation with a cDNA for human acid beta-galactosidase cloned in our laboratory and stable transformants expressing the enzyme activity were selected. The precursor form of the enzyme was secreted in large quantities into the culture medium. The fibroblasts from patients with GM1-gangliosidosis or Morquio B disease showed a remarkable increase of enzyme activity, up to the normal level, after culture in this medium for 2 days; the amount of uptake was essentially the same as that for the precursor form in human fibroblasts. After endocytosis, the precursor molecules were processed normally to the mature form and remained as stable as those produced by human fibroblasts. On the other hand, cells from galactosialidosis patients did not show any increase of enzyme activity in a similar experiment. It was concluded that the transformants are useful as the source of precursor proteins for the study of intracellular turnover of enzyme molecules in mutant cells.
Similar articles
-
Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.Biochem J. 1996 Feb 1;313 ( Pt 3)(Pt 3):787-94. doi: 10.1042/bj3130787. Biochem J. 1996. PMID: 8611156 Free PMC article.
-
Molecular form and subcellular distribution of acid beta-galactosidase in fibroblasts from patients with GM1 gangliosidosis, Morquio B disease and galactosialidosis.Brain Dev. 1997 Mar;19(2):126-30. doi: 10.1016/s0387-7604(96)00494-9. Brain Dev. 1997. PMID: 9105659 Clinical Trial.
-
Intracellular processing and maturation of mutant gene products in hereditary beta-galactosidase deficiency (beta-galactosidosis).Hum Genet. 1994 Feb;93(2):109-14. doi: 10.1007/BF00210592. Hum Genet. 1994. PMID: 8112731
-
Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.Biochim Biophys Acta. 1999 Oct 8;1455(2-3):85-103. doi: 10.1016/s0925-4439(99)00075-7. Biochim Biophys Acta. 1999. PMID: 10571006 Review.
-
[beta-galactosidosis--GM1 gangliosidosis and Morquio B disease].Nihon Rinsho. 1995 Dec;53(12):2960-6. Nihon Rinsho. 1995. PMID: 8577043 Review. Japanese.
Cited by
-
Characterization and purification of human beta-galactosidase overexpressed in recombinant baculovirus-infected Spodoptera frugiperda cells.J Inherit Metab Dis. 1991;14(5):813-8. doi: 10.1007/BF01799955. J Inherit Metab Dis. 1991. PMID: 1779628 No abstract available.
-
SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing.BMC Res Notes. 2008 Dec 29;1:137. doi: 10.1186/1756-0500-1-137. BMC Res Notes. 2008. PMID: 19114006 Free PMC article.
-
Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.Am J Hum Genet. 1991 Aug;49(2):435-42. Am J Hum Genet. 1991. PMID: 1907800 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous